Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. II. Effects of papaverine.
D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000502:physiology; D001341:Autonomic Nervous System / Q000201:enzymology / Q000502:physiology; D001593:Benzyl Compounds / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D004347:Drug Interactions; D004558:Electric Stimulation; D004987:Ethers / Q000494:pharmacology; D005260:Female; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D010208:Papaverine / Q000494:pharmacology*; D010477:Perfusion; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D013154:Spleen / Q000201:enzymology / Q000294:innervation / Q000378:metabolism; D013268:Stimulation, Chemical; D014316:Tritium; D014970:Xanthines / Q000494:pharmacology
D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D014970:Xanthines; D014316:Tritium; D010208:Papaverine; D004299:Dopamine beta-Hydroxylase; D010727:Phosphoric Diester Hydrolases; D002118:Calcium; D009638:Norepinephrine